Insider Transactions in Q4 2024 at Caladrius Biosciences, Inc. (CLBS)
Insider Transaction List (Q4 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Oct 01
2024
|
James Nisco SVP, Fin/Treas, Chief Actg Off |
SELL
Payment of exercise price or tax liability
|
Direct |
1,701
-11.61%
|
$3,402
$2.93 P/Share
|
|
Oct 01
2024
|
James Nisco SVP, Fin/Treas, Chief Actg Off |
BUY
Grant, award, or other acquisition
|
Direct |
3,300
+18.38%
|
$6,600
$2.93 P/Share
|
|
Oct 01
2024
|
Kristen K Buck EVP, R&D and CMO |
SELL
Payment of exercise price or tax liability
|
Direct |
6,363
-9.22%
|
$12,726
$2.93 P/Share
|
|
Oct 01
2024
|
Kristen K Buck EVP, R&D and CMO |
BUY
Grant, award, or other acquisition
|
Direct |
15,000
+17.85%
|
$30,000
$2.93 P/Share
|
|
Oct 01
2024
|
David J Mazzo President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
26,964
-11.29%
|
$53,928
$2.93 P/Share
|
|
Oct 01
2024
|
David J Mazzo President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
58,000
+19.54%
|
$116,000
$2.93 P/Share
|